Phase I Clinical Study of a Static Magnetic Field Combined with Anti-Neoplastic Chemotherapy in the Treatment of Human Malignancy: Initial Safety and Toxicity Data

Bioelectromagnetics

Volumn 24, Issue 7, 2003, Pages 524-527

  Salvatore, Joseph R ^a   Harrington, Joanne ^a   Kummet, Thomas ^a  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

Cancer; Chemotherapy; Human; Static

Indexed keywords

BLOOD; MAGNETIC FIELDS; TOXICITY;

ANTINEOPLASTIC; CANCER; CLINICAL STUDY; HUMAN; HUMAN MALIGNANCIES; PHASE I; SAFETY DATA; STATIC; STATIC MAGNETIC FIELDS; TOXICITY DATA;

CHEMOTHERAPY;

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PLATINUM; PREDNISONE; RITUXIMAB; VINCRISTINE; CHOP PROTOCOL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; CLINICAL TRIAL; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKOCYTE COUNT; MAGNET; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SAFETY; STATIC MAGNETIC FIELD THERAPY; THROMBOCYTE COUNT; TREATMENT OUTCOME; BLOOD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; FEMALE; MAGNETISM; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; RADIATION DOSE; RADIATION RESPONSE; RISK ASSESSMENT; TOXICITY TESTING;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOXORUBICIN; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; LEUKOCYTE COUNT; MAGNETICS; MALE; MIDDLE AGED; NEOPLASMS; PLATELET COUNT; PREDNISONE; RADIATION DOSAGE; RISK ASSESSMENT; TOXICITY TESTS; VINCRISTINE;

EID: 1542389652     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/bem.10149     Document Type: Article

References (16)

1. Alfano A, Taylor A, Foresman P, Dunkl P, McConnell G, Conaway M, Gillies G. 2001. Static magnetic fields for treatment of fibromyalgia: A randomized controlled trial. J Altern Complement Medicine 7:53-64.
2. Curra A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A. 2002. Transcranial magnetic stimulation techniques in clinical investigation. Neurology 59:1851-1859.
3. Daskalakis Z, Christensen B, Fitzgerald P, Chen R. 2002. Transcranial magnetic stimulation: A new investigational and treatment tool in psychiatry. J Neuropsychiatry Clin Neurosci 14:406-415.
4. Gray J, Frith C, Parker J. 2000. In vivo enhancement of chemotherapy with static electric or magnetic fields. BEMS 21:575-583.
5. Hannan C, Liang Y, Allison J, Searle J. 1994. In vitro cytotoxicity against human cancer cell lines during pulsed magnetic field exposure. Anticancer Res 14:1517-1520.
6. R-8-5-11 by a pulsed magnetic field. Antican Res 17:2083-2088.
7. McLean MJ, Engstrom S, Holcomb R. 2001. Static magnetic fields for the treatment of pain. Epilepsy & Behavior 2:S74-S80.
8. Miyagi N, Sato K, Rong Y, Yamamura S, Katagiri H, Kobayashi K, Iwata H. 2000. Effects of PEMF on a murine osteosarcoma cell line: Drug resistant (P-Glycoprotein-positive) and non-resistant cells. BEMS 21:112-121.
9. Raylman R, Clavo A, Wahl R. 1996. Exposure to strong magnetic field slows the growth of human cancer cells in vitro. BEMS 17:358-363.
10. Ryaby JT. 1998. Clinical effects of electromagnetic and electric fields on fracture healing. Clin Orthop 355(Suppl):S205-S215.
11. Sabo J, Mirossay L, Horovcak L, Sarissky M, Mirossay A, Mojzis J. 2002. Effects of static magnetic field on human leukemic cell line HL-60. Bioelectrochemistry 56:227-231.
12. Salvatore J, Blackinton D, Polk C, Mehta S. 1994. Non-ionizing electromagnetic radiation: A study of carcinogenic and cancer treatment potential. Rev Env Health 10:197-207.
13. Segal N, Toda Y, Huston J, Saeki Y, Shimizu M, Fuchs H, Shimaoka Y, Holcomb R, McLean M. 2001. Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: A double-blind clinical trial. Arch Phys Med Rehab 82:1453-1460.
14. Simon R. 2001. Design and analysis of clinical trials. In: DeVita V, Hellman S, Rosenberg S, editors. Cancer: Principles and practice of oncology. Philadelphia: Lippincott, Williams, and Wilkins. pp 521-523.
15. Tofani S, Barone D, Cintorino M, de Santi M, Ferrara A, Orlassino R, Ossola P, Peroglio F, Rolfo K, Ronchetto F. 2001. Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. BEMS 22:419-428.
16. Valbona C, Hazelwood C, Jurida G. 1997. Response of pain to static magnetic fields in postpolio patients: A double blind pilot study. Arch Phys Med Rehab 78:1200-1203.